| Woolworths Group Limited (WOW) ORDINARY FULLY PAID |
Consumer Staple |
$39,091 |
Appendix 4E and Annual Report
|
28 Aug 2024 8:30AM |
$35.460 |
$32.000 |
fallen by
9.76%
|
|
WOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Woolworths Group Limited released its Appendix 4E and Annual Report.
- The report includes financial performance, operational highlights, and strategic initiatives.
- Woolworths had a strong financial year with significant growth in revenue and profit.
- The company focused on sustainability and community engagement.
- There were numerous governance and risk management measures discussed.
- Woolworths detailed its future outlook and strategic priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$2,553 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2024 8:30AM |
$1.340 |
$1.610 |
risen by
20.15%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$2,553 |
Final Results Presentation
|
28 Aug 2024 8:29AM |
$1.340 |
$1.610 |
risen by
20.15%
|
|
NEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Nine Entertainment Co. Holdings Limited (NEC) presented its FY24 financial results on August 28, 2024.
- NEC reported a 3% decrease in Group Revenue to $2.6 billion.
- Group EBITDA decreased by 12% to $517.4 million.
- NEC's Group Strategy focuses on maximising monetisation across multiple revenue models, creating Australia's best content, and integrating data and audience platforms.
- Key achievements include a 15% growth in targeted ad revenues, launch of Nine Ad Manager, and expansion of relationships with Google.
- NEC achieved significant growth in digital revenues, making up approximately 50% of total Group revenue.
- Subscription and licensing contributed to about 31% of Group revenue, with a 5% revenue growth from subscription and licensing.
- NEC's cost performance was solid, with around $65 million of costs removed, supporting ongoing investment in growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$2,553 |
Final Results Announcement
|
28 Aug 2024 8:29AM |
$1.340 |
$1.610 |
risen by
20.15%
|
|
NEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Nine Entertainment Co. reported revenue of $2.6 billion for FY24.
- Net Profit After Tax was $134.9 million, including a post-tax Specific Item expense of $81.5 million.
- Group EBITDA before Specific Items was $517 million, a 12% decline from FY23.
- Total Television audiences grew, leading to a positive revenue outlook.
- Subscription & licensing revenues (excluding Domain) grew by 5%, contributing 31% to wholly-owned Group Revenue.
- Domain's EBITDA contribution to Nine grew by 32%, driven by new listings and increased Average Revenue Per Listing.
- Digital revenue in Audio grew by 35%, with leadership in live streaming audiences.
- $65 million cost efficiencies were achieved, with an additional $100 million expected over FY24 and FY25.
- A final dividend of 4.5 cents per share was declared, totaling 8.5 cents for the year, fully franked.
- The Paris Olympics significantly boosted Q1 FY25 revenue and audience performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$2,553 |
Full Year Statutory Accounts
|
28 Aug 2024 8:29AM |
$1.340 |
$1.610 |
risen by
20.15%
|
|
NEC - Price-sensitive ASX Announcement
Full Release
Key Points
- Nine Entertainment Co. Holdings Limited reported a consolidated net profit after income tax of $134.9 million for the year ending 30 June 2024.
- Group revenues decreased by 3% to $2,629.81 million.
- EBITDA before specific items was $517.41 million.
- Cash flows generated in operations were $293.42 million.
- Significant on-market buyback of shares commenced in September 2022, with 119,631,130 shares purchased by 30 June 2024 for a total cost of $221.5 million.
- No significant events occurred after the balance sheet date that would affect the operations or state of affairs of the consolidated entity.
- No unissued ordinary shares or options existed as of the report date.
- Indemnification and insurance premiums were paid for directors and officers.
- Principal activities included broadcasting, program production, publishing, real estate media and technology services, and subscription video on demand.
- An interim dividend of 4.0 cents per share was paid, with a proposed final dividend of 4.5 cents per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| City Chic Collective Limited (CCX) ORDINARY FULLY PAID |
Consumer Discretionary |
$30 |
FY24 Results Investor Presentation
|
28 Aug 2024 8:29AM |
$0.103 |
$0.078 |
fallen by
23.90%
|
|
CCX - Price-sensitive ASX Announcement
Full Release
Key Points
- Business transformation completed with sale of Avenue, brand refresh, and inventory normalization.
- Positive momentum in the first 8 weeks of FY25 with a 28% increase in Trading Gross Margin and a 58% rise in Average Selling Price.
- FY25 financial targets set at $142-$160 million in revenue and $11-$18 million in EBITDA post AASB16.
- City Chic's strategy focuses on a higher value customer base in ANZ and the US.
- Significant cost reduction initiatives delivering $20.3 million in savings, with 85% already implemented.
- Inventory returned to normalized levels and typical purchasing cycles.
- FY24 EBITDA was approximately 10% ahead of the proforma adjusted forecast.
- Expectation of continued trends in higher Average Selling Price and Gross Margin from H2 FY24 into FY25.
- Dedicated single brand offering focused on the higher value City Chic customer in ANZ and the US.
- Focus on profitable and sustainable long-term growth amidst uncertain trading conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| City Chic Collective Limited (CCX) ORDINARY FULLY PAID |
Consumer Discretionary |
$30 |
FY24 Results Announcement
|
28 Aug 2024 8:27AM |
$0.103 |
$0.078 |
fallen by
23.90%
|
|
CCX - Price-sensitive ASX Announcement
Full Release
Key Points
- FY24 Sales Revenue of $131.6m, down 28.3% on FY23
- FY24 Underlying EBITDA loss of $8.4m, 47.3% improvement on FY23
- Inventory down 42.8% to $30.7m as at 30 June 2024
- Net cash position of $3.9m as at 30 June 2024
- Business restructure to deliver $20.3m in cost savings
- Trading Gross Margin dollars up ~28% on PCP in first 8 weeks of FY25
- Strengthened balance sheet through divestment of Avenue and Equity Raise
- Targeting revenue of $142m-$160m and EBITDA post AASB 16 of $11-18m in FY25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$136 |
FY24 Preliminary Report and FY25 Guidance
|
28 Aug 2024 8:27AM |
$0.375 |
$0.630 |
risen by
68%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- FY24 revenue of $91.7 million, up 9.6% from FY23.
- Product gross margin of 69% in FY24, compared to 72% in FY23.
- EBITDA of $0.6 million in FY24, within the revised guidance.
- Net cash inflow of $4.2 million for FY24, compared to a net cash outflow of $3.7 million in FY23.
- SomnoMed had $16.2 million in available cash as of 30 June 2024.
- One-off restructuring costs of $3.0 million in FY24, with annualized savings of $5 million expected from Q1 FY25.
- Total patients treated worldwide now exceed 910,000.
- FY25 revenue guidance of approximately $100 million.
- FY25 EBITDA guidance of more than $5 million.
- FY25 Capex guidance between $3 million and $4 million.
- 20% revenue increase in the first 8 weeks of FY25 year-on-year.
- Ongoing communication with US FDA for Rest Assure® product approval expected by early September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telstra Group Limited (TLS) ORDINARY FULLY PAID |
Communication Services |
$55,613 |
Telstra Group Limited 2024 Annual Report
|
28 Aug 2024 8:27AM |
$4.000 |
$4.870 |
risen by
21.75%
|
|
| City Chic Collective Limited (CCX) ORDINARY FULLY PAID |
Consumer Discretionary |
$30 |
FY24 Appendix 4E and Financial Statements
|
28 Aug 2024 8:26AM |
$0.103 |
$0.078 |
fallen by
23.90%
|
|
CCX - Price-sensitive ASX Announcement
Full Release
Key Points
- No dividends were paid, recommended, or declared during the current or previous financial period.
- City Chic made the strategic decision to sell the Avenue brand and exit the EMEA region.
- The Group executed business transformation initiatives aimed at returning to a position of strength.
- City Chic's key operating metrics saw strong improvements: Gross Margin up 28 percentage points and Average Sell Price up 60% in Q4 compared to the prior year.
- Actions following the sale of Avenue are expected to deliver $20.3 million in savings.
- The Group's customer base remains strong at approximately 481,000 with a Net Promoter Score of 72.
- City Chic has a significant presence with 76 stores in Australia and New Zealand and operates websites in ANZ and the USA.
- Loss from continuing operations was $38.4 million, and from discontinued operations was $54.6 million, culminating in a total loss of $93 million.
- Underlying EBITDA from continuing operations improved by 47.3% to a loss of $8.4 million.
- Net tangible assets per ordinary security decreased from 20.8 cents to 5.3 cents.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SomnoMed Limited (SOM) ORDINARY FULLY PAID |
Health Care |
$136 |
Preliminary Final Report
|
28 Aug 2024 8:26AM |
$0.375 |
$0.630 |
risen by
68%
|
|
SOM - Price-sensitive ASX Announcement
Full Release
Key Points
- FY24 revenue of $91.7 million, up 9.6% on FY23
- Gross margin of 69%
- EBITDA of $0.6 million
- Net cash inflow of $4.2 million
- Available cash of $16.2 million as of 30 June 2024
- One-off restructuring costs of $3.0 million with annualised savings of $5 million
- Total patients treated worldwide now exceeds 910,000
- Revenue growth in North America, Europe, and APAC
- Detailed financial statements including profit or loss, changes in equity, and cash flows
- FY25 guidance includes revenue of approximately $100 million and EBITDA of more than $5 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$303 |
NTA at 23.08.24 Pre-tax 130.59 Post-tax 129.80
|
28 Aug 2024 8:25AM |
$1.120 |
$1.180 |
risen by
5.36%
|
|
| 3D Energi Limited (TDO) ORDINARY FULLY PAID |
Energy |
$42 |
2024 Annual Report to Shareholders
|
28 Aug 2024 8:24AM |
$0.072 |
$0.125 |
risen by
73.61%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$71 |
FY24 Results Presentation
|
28 Aug 2024 8:22AM |
$1.950 |
$1.500 |
fallen by
23.08%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth of 79% from $37.1m in FY23 to $66.4m in FY24.
- Gross margin stable above 75% for the period.
- Strong cash position of $19.0m with no external debt.
- Significant market expansion into new distribution channels like Kuaishou and Pinduoduo in China, and new geographies like Vietnam.
- Launch of 21 new products under the EZZ brand.
- Record revenue growth driven by market-driven R&D, dynamic channel prioritization, and targeted B2C marketing.
- EBITDA increased by 103.80% year-over-year, reaching $10.4m.
- Net Profit After Tax (NPAT) grew by 91.8% year-over-year to $6.9m.
- Plans to enter the US market with a TikTok store and launch 10 new products in 1H FY25.
- Strategic relationships expected to drive strong growth in the Chinese market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$678 |
Final Dividend Details 31 August 2024
|
28 Aug 2024 8:21AM |
$0.995 |
$1.028 |
risen by
3.27%
|
|
| Sovereign Metals Limited (SVM) ORDINARY FULLY PAID |
Materials |
$459 |
Hydraulic Mining Trial Commences
|
28 Aug 2024 8:21AM |
$0.605 |
$0.710 |
risen by
17.36%
|
|
SVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Hydraulic mining trial commenced at Kasiya Pilot Site
- The trial is part of the ongoing Optimisation Study
- Conducted by Fraser Alexander, a leader in hydraulic mining
- Expected to take approximately three months, includes backfilling and rehabilitation testwork
- Kasiya’s soft, friable orebody is suitable for hydraulic mining
- Oversight by Sovereign-Rio Tinto Technical Committee
- Rio Tinto increases its shareholding to 19.9% with an additional investment of A$0.7 million
- Pilot Phase includes processing, backfilling material, and progressing towards rehabilitation
- No drilling, blasting, crushing, grinding, or milling needed before stockpiling material
- Land rehabilitation aims to restore land post-mining to match or surpass existing agricultural yields
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Origin Energy Limited (ORG) ORDINARY FULLY PAID |
Utilities |
$18,244 |
Changes to the Origin Board
|
28 Aug 2024 8:21AM |
$9.910 |
$10.590 |
risen by
6.86%
|
|
| Hiremii Limited (HMI) ORDINARY FULLY PAID |
Industrials |
$8 |
2024 Annual General Meeting - Key Dates
|
28 Aug 2024 8:20AM |
$0.045 |
$0.051 |
risen by
13.33%
|
|
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$107 |
FY24 Results Webinar
|
28 Aug 2024 8:20AM |
$0.092 |
$0.110 |
risen by
19.57%
|
|
| Telstra Group Limited (TLS) ORDINARY FULLY PAID |
Communication Services |
$55,613 |
Notice of 2024 Annual General Meeting
|
28 Aug 2024 8:20AM |
$4.000 |
$4.870 |
risen by
21.75%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$71 |
FY24 Full Year Results Summary
|
28 Aug 2024 8:19AM |
$1.950 |
$1.500 |
fallen by
23.08%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $66.4m, up 78.9% on the previous corresponding period (PcP)
- EBITDA of $10.4m, up 103.8% on the PcP
- Gross margin remained above 75% in FY24
- NPAT of $6.9m, up 91.8% on the PcP
- Operating cash flow of $6.2m, up 55% on the PcP
- Balance sheet strengthened with a cash position of $19.0m at 30 June 2024, up 37.5% on the PcP
- Fully franked interim dividend of $0.015 per share in FY24, up from $0.0098 per share in FY23
- Launched 21 new EZZ products in FY24, bringing the total active product portfolio to 53 SKUs
- Introduced 10 new distribution channels and expanded networks across key platforms including Douyin, Tmall Global, Kuaishou, Aubay, and O’Mall
- Growing brand awareness in the Chinese market
- Targeting US market expansion in FY25 by successfully obtaining FDA approvals for nine EZZ products in the food category
- Secured a strategic investor and a major sales agreement to expand distribution channels in existing and new markets within Southeast Asia
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canterbury Resources Ltd (CBY) ORDINARY FULLY PAID |
Materials |
$6 |
Outstanding Drill Result at Briggs
|
28 Aug 2024 8:18AM |
$0.030 |
$0.027 |
fallen by
10%
|
|
CBY - Price-sensitive ASX Announcement
Full Release
Key Points
- Canterbury Resources Limited reported assay results for the first hole, 24BRD0026, in the 2024 drilling program at the Briggs copper-molybdenum project.
- Hole 24BRD0026 drilled to a depth of 283.9m intersected strong copper mineralisation, recording 276m at 0.45% Cu from surface, including multiple higher-grade intervals.
- Around 50% of the mineralisation in 24BRD0026 occurs outside the current boundary of the Briggs Central inferred resource.
- The drilling program is testing for near-surface, higher-grade copper mineralisation and aims to support a higher-grade starter-pit in a conceptual mining operation.
- Infill drilling is being undertaken to upgrade resource confidence to initiate a Scoping Study later in the year.
- Drilling in the area is continuing with holes 24BRD0027 and 24BRD0028 completed and hole 24BRD0029 nearing completion.
- Funding for the 2024 program is provided by Alma Metals Limited under an Earn-in Joint Venture Agreement, with Alma Metals expected to increase its project interest to 51% by meeting Stage-2 expenditure requirements this year.
- The Briggs deposit comprises an Inferred Resource (MRE) of 415Mt at 0.25% Cu and 31ppm Mo, with an exploration target of 480Mt to 880Mt at 0.20% to 0.30% Cu and 25ppm to 40ppm Mo.
- Preliminary metallurgical test-work has achieved high copper recoveries (92-95%) via standard crushing, grinding, and flotation.
- Copper mineralisation transitions from copper oxides and malachite at surface to chalcopyrite and secondary chalcocite at depth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$8,646 |
Telix Submits NDA for TLX101-CDx Brain Cancer Imaging Agent
|
28 Aug 2024 8:17AM |
$19.970 |
$25.560 |
risen by
27.99%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix Pharmaceuticals Limited submits NDA to FDA for TLX101-CDx (Pixclara®) for brain cancer imaging.
- TLX101-CDx is a PET agent for glioma characterisation.
- Pixclara® has Orphan Drug and Fast Track designations by FDA.
- FET PET (Pixclara®) is included in international clinical practice guidelines.
- There is a critical unmet need in glioma diagnosis and management.
- Pixclara® aims to improve diagnosis and treatment decision-making for glioma patients.
- Pixclara® is also developed as a companion theranostic imaging agent for TLX101.
- Gliomas are the most common primary brain tumours with low survival rates.
- Conventional imaging methods like MRI have limitations for glioma characterisation.
- Telix's NDA submission for Pixclara® reflects commitment to neuro-oncology imaging improvements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$481 |
Dividend/Distribution - ADH
|
28 Aug 2024 8:17AM |
$2.050 |
$2.720 |
risen by
32.68%
|
|
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$481 |
ADH FY2024 Corporate Governance Statement and Appendix 4G
|
28 Aug 2024 8:16AM |
$2.050 |
$2.720 |
risen by
32.68%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
